{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:27:35Z","timestamp":1793147255764,"version":"4.5.0"},"reference-count":414,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000765","name":"UCL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG - Id.27667"],"award-info":[{"award-number":["IG - Id.27667"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.mam.2023.101231","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T23:12:36Z","timestamp":1701731556000},"page":"101231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":228,"special_numbering":"C","title":["Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies"],"prefix":"10.1016","volume":"95","author":[{"given":"Maurizio","family":"Parola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2023.101231_bib422","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. AASLD-IDSAHCV panel","volume":"67","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101231_bib1","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101231_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/gut.2004.057968","article-title":"Immune response toward lipid peroxidation products as a predictor of the progression of non- alcoholic fatty liver disease (NAFLD) to advanced fibrosis","volume":"54","author":"Albano","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0037-1601350","article-title":"Inflammasomes in liver fibrosis","volume":"37","author":"Alegre","year":"2017","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.mam.2023.101231_bib420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/hep.24721","article-title":"Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis","volume":"55","author":"Alkhouri","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hep4.1146","article-title":"Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease","volume":"2","author":"Amer","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/egh.11.4","article-title":"Autophagy in nonalcoholic steatohepatitis","volume":"5","author":"Amir","year":"2011","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib9","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","article-title":"Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease","volume":"150","author":"Anstee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-022-03330-7","article-title":"Neutrophil extracellular traps enriched with IL-1\u03b2 and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis","volume":"481","author":"Arelaki","year":"2022","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mam.2023.101231_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib421","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-020-00292-x","article-title":"Deciphering cell-cell interactions and communication from gene expression","volume":"22","author":"Armingol","year":"2021","journal-title":"Nat. Rev, Gen."},{"key":"10.1016\/j.mam.2023.101231_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000444471","article-title":"The pathogenesis of autoimmune liver disease","volume":"34","author":"Arndtz","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.mam.2023.101231_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.22721","article-title":"Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development","volume":"49","author":"Asahina","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.24119","article-title":"Septum transversum- derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver","volume":"53","author":"Asahina","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/tgh.2020.01.04","article-title":"Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry","volume":"6","author":"Asgharpour","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mam.2023.101231_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","article-title":"T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma","volume":"77","author":"Barsch","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.molmet.2016.06.003","article-title":"Non- alcoholic fatty liver and the gut microbiota","volume":"5","author":"Bashiardes","year":"2016","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101231_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib26","article-title":"Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis","volume":"3","author":"Bhattacharya","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.mam.2023.101231_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib28","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.immuni.2021.08.006","article-title":"A subset of Kupffer cells regulates metabolism through the expression of CD36","volume":"54","author":"Bl\u00e9riot","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2023.101231_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fasebj.5.3.2001786","article-title":"Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis","volume":"5","author":"Blomhoff","year":"1991","journal-title":"Faseb. J."},{"key":"10.1016\/j.mam.2023.101231_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcmgh.2015.06.011","article-title":"Angiogenesis and fibrogenesis in chronic liver diseases","volume":"1","author":"Bocca","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib31","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/antiox11071278","article-title":"Hepatic myofibroblasts: a heterogeneous and redox-modulated cell population in liver fibrogenesis","volume":"11","author":"Bocca","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.mam.2023.101231_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R\/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.mam.2023.101231_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2023.101231_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/hep.29782","article-title":"MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation","volume":"68","author":"Bottcher","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2958.2000.02103.x","article-title":"Salmonella induces macrophage death by caspase-1-dependent necrosis","volume":"38","author":"Brennan","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.mam.2023.101231_bib409","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","volume":"318","author":"Breuer","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mam.2023.101231_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fendo.2020.00555","article-title":"Shaping of dendritic cell function by the metabolic micro-environment","volume":"11","author":"Brombacher","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2023.101231_bib38","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.4049\/jimmunol.1001623","article-title":"Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1\u03b2-rich microparticles","volume":"186","author":"Brown","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30418","article-title":"Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic dteatohepatitis: results from the nonalcoholic steatohepatitis clinical research metwork treatment trials","volume":"70","author":"Brunt","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib41","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2022.01.011","article-title":"Complexity of ballooned hepatocyte feature recognition: defining a training atlas for artificial intelligence-based imaging in NAFLD","volume":"76","author":"Brunt","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib42","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/hep.29041","article-title":"The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells","volume":"65","author":"Bruschi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Bruzz\u00ec","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mam.2023.101231_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.mam.2023.101231_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0041-1739455","article-title":"The neglected role of bile duct epithelial cells in NASH","volume":"42","author":"Cadamuro","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis","volume":"31","author":"Cai","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib47","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1053\/jhep.2003.50472","article-title":"Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression","volume":"38","author":"Canbay","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"83","author":"Canbay","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2017.05.017","article-title":"Therapeutic pro-fibrogenic signaling pathways in fibroblasts","volume":"121","author":"Cannito","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.mam.2023.101231_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172575","article-title":"Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: a pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis","volume":"12","author":"Cannito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib51","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.3390\/ijms19123875","article-title":"Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies","volume":"19","author":"Cannito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib52","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221271","article-title":"Inflammatory processes involved in NASH-related hepatocellular carcinoma","volume":"43","author":"Cannito","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.mam.2023.101231_bib53","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fimmu.2017.00164","article-title":"Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model","volume":"8","author":"Carlos","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.867940","article-title":"Hepatic stellate cell-immune interactions in NASH","volume":"13","author":"Carter","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2023.101231_bib55","series-title":"Noninvasive Assessment of Liver Disease in Patients with Nonalcoholic Fatty Liver Disease. Gastroenterology","first-page":"1264","volume":"vol. 156","author":"Castera","year":"2019"},{"key":"10.1016\/j.mam.2023.101231_bib56","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cyto.2016.01.020","article-title":"Interleukin-15-mediated inflammation promotes non- alcoholic fatty liver disease","volume":"82","author":"Cepero-Donates","year":"2016","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.mam.2023.101231_bib410","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.mam.2023.101231_bib58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib59","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/hep.27233","article-title":"Dual role of B7 costimulation in obesity- related nonalcoholic steatohepatitis and metabolic dysregulation","volume":"60","author":"Chatzigeorgiou","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib60","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bbrc.2019.08.111","article-title":"Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism","volume":"518","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib61","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"J. Hep. Rep."},{"key":"10.1016\/j.mam.2023.101231_bib62","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/a-1877-9656","article-title":"Nonalcoholic steatohepatitis drug development pipeline: an update","volume":"42","author":"Chew","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib63","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib423","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am. J. Physiol. Gastroint. Liver Physiol."},{"key":"10.1016\/j.mam.2023.101231_bib64","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3389\/fimmu.2019.02180","article-title":"The obese liver environment mediates conversion of NK cells to a less cytotoxic ILC1-like phenotype","volume":"10","author":"Cuff","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib65","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.28674","article-title":"Shared genetic effects between hepatic steatosis and fibrosis: a prospective twin study","volume":"64","author":"Cui","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib66","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10620-015-4025-x","article-title":"Function of autophagy in nonalcoholic fatty liver disease","volume":"61","author":"Czaja","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib67","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.3748\/wjg.v27.i25.3705","article-title":"Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease","volume":"27","author":"Czaja","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mam.2023.101231_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2023.101231_bib69","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3389\/fimmu.2019.02988","article-title":"Optimization of in vivo imaging provides a first look at mouse model of non-alcoholic fatty liver disease (NAFLD) using intravital microscopy","volume":"10","author":"Davis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib70","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chit\u201d","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib71","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib72","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","article-title":"XCR1(+) type 1 conventional dendritic cells drive liver pathology in nonalcoholic steatohepatitis","volume":"27","author":"Deczkowska","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib424","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"di Bonzo","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12026-010-8189-3","article-title":"B- lymphocyte effector functions in health and disease","volume":"49","author":"Di Lillo","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.mam.2023.101231_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230307","article-title":"Characterization of the immune cell landscape of patients with NAFLD","volume":"15","author":"Diedrich","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib76","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib77","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","article-title":"Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis","volume":"29","author":"Dobie","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2023.101231_bib78","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","article-title":"MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals","volume":"7","author":"Donati","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2023.101231_bib79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12719","article-title":"Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver","volume":"283","author":"Dongiovanni","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mam.2023.101231_bib80","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/hep.23405","article-title":"Portal fibroblasts: underappreciated mediators of biliary fibrosis","volume":"51","author":"Dranoff","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib81","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib82","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib83","first-page":"179","article-title":"The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation","volume":"6","author":"Eckert","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib84","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-3-319-48382-5_19","article-title":"Non-alcoholic fatty liver disease","volume":"960","author":"Engin","year":"2017","journal-title":"Obes. Lipotoxic."},{"key":"10.1016\/j.mam.2023.101231_bib85","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib86","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib88","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib91","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib92","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib93","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mam.2023.101231_bib94","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.20283","article-title":"Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway","volume":"40","author":"Feldstein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib95","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10875-011-9635-2","article-title":"The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis","volume":"32","author":"Ferreyra Solari","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib96","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.2337\/db12-0206","article-title":"Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly","volume":"61","author":"Flannery","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.mam.2023.101231_bib97","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/cells10071764","article-title":"Hypoxia, hypoxia-inducible factors and liver fibrosis","volume":"10","author":"Foglia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mam.2023.101231_bib98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpg.2011.02.006","article-title":"Liver fibrogenic cells","volume":"25","author":"Forbes","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.mam.2023.101231_bib99","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1053\/j.gastro.2004.02.025","article-title":"A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis","volume":"126","author":"Forbes","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib101","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101231_bib102","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2021.12.004","article-title":"A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH","volume":"76","author":"Fraser","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mam.2023.101231_bib104","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib106","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/hepr.12282","article-title":"Abnormality of autophagic function and cathepsin expression in the liver from patients with nonalcoholic fatty liver disease","volume":"44","author":"Fukuo","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.mam.2023.101231_bib107","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib108","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.mam.2023.101231_bib109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.15252\/emmm.201403856","article-title":"A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis","volume":"6","author":"Gautheron","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2023.101231_bib111","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","volume":"72","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib112","doi-asserted-by":"crossref","first-page":"eaai7616","DOI":"10.1126\/sciimmunol.aai7616","article-title":"Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome","volume":"2","author":"Ghazarian","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.mam.2023.101231_bib113","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mam.2023.101231_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149783","article-title":"Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis","volume":"11","author":"Giles","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/hep4.1237","article-title":"Serum interleukin-8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease","volume":"2","author":"Glass","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib116","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2023.01.001","article-title":"Nonalcoholic fatty liver disease: disease burden and disease awareness","volume":"27","author":"Golabi","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib117","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2023.101231_bib118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib119","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.4049\/jimmunol.1003965","article-title":"IL-15 regulates homeostasis and terminal maturation of NKT cells","volume":"187","author":"Gordy","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mam.2023.101231_bib121","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2023.101231_bib122","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.mam.2023.101231_bib123","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib124","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","article-title":"NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis","volume":"61","author":"Gur","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1109ds87","article-title":"TRAF- mediated TNFR- family signaling","author":"Ha","year":"2009","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.mam.2023.101231_bib127","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1002\/eji.200939922","article-title":"CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma producing gammadelta effector T cells","volume":"39","author":"Haas","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s42255-019-0076-1","article-title":"Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution","volume":"1","author":"Haas","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.mam.2023.101231_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/839275","article-title":"Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?","volume":"2013","author":"Hafeez","year":"2013","journal-title":"J. Obes."},{"key":"10.1016\/j.mam.2023.101231_bib130","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib131","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.26697","article-title":"Chemokine receptor CCR6-dependent accumulation of \u03b3\u03b4 T cells in injured liver restricts hepatic inflammation and fibrosis","volume":"59","author":"Hammerich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib132","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/hep.26746","article-title":"IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice","volume":"59","author":"Harley","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib133","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41591-022-01861-9","article-title":"Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study","volume":"28","author":"Harrison","year":"2022","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.mam.2023.101231_bib134","first-page":"3","article-title":"Clinical trial landscape in NASH","volume":"S1542\u20133565","author":"Harrison","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib135","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib136","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hep.31106","article-title":"Liver-on-a-Chip models of fatty liver disease","volume":"71","author":"Hassan","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib137","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"Hegde","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib138","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules . . . or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.mam.2023.101231_bib139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome- mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao- Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib140","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/nm.3282","article-title":"Targeting of \u03b1v integrin identifies a core molecular pathway that regulates fibrosis in several organs","volume":"19","author":"Henderson","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib141","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.26267","article-title":"Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice","volume":"58","author":"Henning","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib142","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.tem.2016.06.005","article-title":"The sweet path to metabolic demise: fructose and lipid synthesis","volume":"27","author":"Herman","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib143","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib144","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2023.101231_bib146","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmgh.2014.11.005","article-title":"Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis","volume":"1","author":"Hirsova","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib147","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","author":"Hirsova","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mam.2023.101231_bib148","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep4.1069","article-title":"TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet- induced obesity","volume":"1","author":"Hirsova","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib149","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12079-020-00554-7","article-title":"Neutralizing antibody against osteopontin attenuates non-alcoholic steatohepatitis in mice","volume":"14","author":"Honda","year":"2020","journal-title":"J. Cell. Commun. Signal."},{"key":"10.1016\/j.mam.2023.101231_bib150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib151","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135197","article-title":"TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis","volume":"131","author":"Hou","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib152","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib153","doi-asserted-by":"crossref","first-page":"23","DOI":"10.11152\/mu-942","article-title":"Acoustic Radiation Force Impulse (ARFI) Elastography for non invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis","volume":"19","author":"Hu","year":"2017","journal-title":"Med. Ultrason."},{"key":"10.1016\/j.mam.2023.101231_bib154","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib417","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.mam.2023.101231_bib155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib156","article-title":"Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis","volume":"1867","author":"Hughey","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.mam.2023.101231_bib157","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/JEP.S265286","article-title":"Experimental and investigational targeted therapies for the management of fibrosis in NASH: an update","volume":"13","author":"Huisman","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.mam.2023.101231_bib158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-0716-2128-8_15","article-title":"Single cell RNA sequencing in NASH","volume":"2455","author":"Hundertmark","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mam.2023.101231_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2023.101231_bib160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib161","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/hep.28252","article-title":"Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes","volume":"63","author":"Ibrahim","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib162","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","article-title":"Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation","volume":"67","author":"Ibrahim","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib163","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jhep.2014.11.033","article-title":"TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess","volume":"62","author":"Idrissova","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib164","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.21070","article-title":"Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression","volume":"43","author":"Ikura","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib165","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib166","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.mam.2023.101231_bib415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.mam.2023.101231_bib167","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid associated macrophages control metabolic homeostasis in a trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mam.2023.101231_bib168","doi-asserted-by":"crossref","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities","volume":"279","author":"Jenkins","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2023.101231_bib169","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib170","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.24190","article-title":"Suppression of innate immunity (natural killer cell\/interferon-\u03b3) in the advanced stages of liver fibrosis in mice","volume":"53","author":"Jeong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib171","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib172","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/ijms24032509","article-title":"Role of B Cell-Activating factor in fibrosis progression in a murine model of non-alcoholic steatohepatitis","volume":"24","author":"Kanemitsu-Okada","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib173","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.23894","article-title":"The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes","volume":"52","author":"Karlmark","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib174","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In vitro models for the study of liver biology and diseases: advances and limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib176","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Non-obese fatty liver disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib177","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mam.2023.101231_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315309","article-title":"Increased number of mucosal-associated invariant T cells is associated with the inhibition of nonalcoholic fatty liver disease in high fat diet-fed mice","volume":"23","author":"Kishi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib179","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib180","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2023.101231_bib181","first-page":"1313","article-title":"Nonalcoholic steatohepatitis clinical research network","volume":"41","author":"Kleiner","year":"2005","journal-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167271","article-title":"Pyroptosis in steatohepatitis and liver diseases","volume":"434","author":"Knorr","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mam.2023.101231_bib183","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","article-title":"Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signalling","volume":"79","author":"Kotsiliti","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib184","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"27","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.23292","article-title":"Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis","volume":"51","author":"Kremer","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib186","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0037-1604480","article-title":"Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism","volume":"37","author":"Krenkel","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib187","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib411","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.mam.2023.101231_bib188","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells8050503","article-title":"Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis","volume":"8","author":"Krenkel","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.mam.2023.101231_bib189","doi-asserted-by":"crossref","first-page":"G599","DOI":"10.1152\/ajpgi.00418.2015","article-title":"Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice","volume":"311","author":"Kwanten","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mam.2023.101231_bib191","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/ncomms7282","article-title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL","volume":"6","author":"Lawlor","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib192","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.mam.2023.101231_bib193","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","article-title":"Defining comprehensive models of care for NAFLD","volume":"18","author":"Lazarus","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib194","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/joim.13380","article-title":"Inflammatory and fibrotic mechanisms in NAFLD \u2013 implications for new treatment strategies","volume":"291","author":"Lee","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mam.2023.101231_bib195","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","article-title":"Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro","volume":"78","author":"Leite","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.mam.2023.101231_bib197","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2005.8.3","article-title":"Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging","volume":"8","author":"Lemasters","year":"2005","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.mam.2023.101231_bib198","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00441-016-2443-5","article-title":"Portal myofibroblasts connect angiogenesis and fibrosis in liver","volume":"365","author":"Lemoinne","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.mam.2023.101231_bib414","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib199","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non- alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.20826","article-title":"Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease","volume":"42","author":"Li","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib201","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2023.101231_bib202","article-title":"The microbiota maintain homeostasis of liver-resident cdT-17 cells in a lipid antigen\/CD1ddependent manner","volume":"7","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib203","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut- liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib204","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2017.11.033","article-title":"TM6SF2: a novel target for plasma lipid regulation","volume":"268","author":"Li","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mam.2023.101231_bib205","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3389\/fimmu.2018.01994","article-title":"Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib206","article-title":"The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: a systematic review and meta-analysis","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib209","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","article-title":"Identification of lineage specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mam.2023.101231_bib211","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib212","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","article-title":"Macrophage autophagy protects against liver fibrosis in mice","volume":"11","author":"Lodder","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.mam.2023.101231_bib213","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30946","article-title":"The 20% rule of NASH progression: the natural history of advanced fibrosis and cirrhosis due to NASH","volume":"70","author":"Loomba","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib214","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib215","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib416","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.mam.2023.101231_bib216","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib217","first-page":"680","article-title":"NASH clinical trial design international working group","volume":"162","author":"Loomba","year":"2022","journal-title":"Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis. Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib412","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2023.101231_bib219","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell death and cell death responses in liver disease: mechanisms and clinical relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib220","doi-asserted-by":"crossref","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","article-title":"IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high fat diet","volume":"305","author":"Luo","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mam.2023.101231_bib418","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine- producing B lymphocytes- key regulators of immunity","volume":"20","author":"Lund","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib221","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib222","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2016.07.045","article-title":"The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans","volume":"65","author":"Luukkonen","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib223","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-023-37453-5","article-title":"MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming","volume":"14","author":"Mabire","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib224","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib225","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/gutjnl-2014-307362","article-title":"Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis","volume":"64","author":"Machado","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib226","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib227","series-title":"details\/madrigal-announces-positive-topline-results-pivotal-phase-3. [cited 27 March","article-title":"Positive topline results from the pivotal phase 3 MAESTRO-NASH clinical trial of resmetirom for the treatment of NASH and liver fibrosis","year":"2023"},{"key":"10.1016\/j.mam.2023.101231_bib228","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.cgh.2017.02.031","article-title":"Diagnostic accuracy of noninvasive fibrosis scores in a population of individuals with a low prevalence of fibrosis","volume":"15","author":"Mahady","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib229","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2023.101231_bib230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib231","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib232","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101231_bib233","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.mam.2023.101231_bib234","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.mam.2023.101231_bib235","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential activation of hepatic invariant NKT cell subsets plays a key role in progression of nonalcoholic steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib419","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"Marra","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mam.2023.101231_bib236","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib237","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib238","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3389\/fimmu.2018.02082","article-title":"Complex network of NKT cell subsets controls immune homeostasis in liver and gut","volume":"9","author":"Marrero","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640869","article-title":"Revisiting the role of natural killer cells in non-alcoholic fatty liver disease","volume":"12","author":"Martinez-Chantar","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addr.2017.05.018","article-title":"Engineering in vitro models of hepatofibrogenesis","volume":"121","author":"Mazza","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2023.101231_bib241","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI88876","article-title":"Role of innate and adaptive immunity in obesity- associated metabolic disease","volume":"127","author":"McLaughlin","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib242","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2014.01.010","article-title":"Serum immunoglobulin levels predict fibrosis in patients with non- alcoholic fatty liver disease","volume":"60","author":"McPherson","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib243","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib244","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib246","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cld.1172","article-title":"Intermittent fasting as a treatment for nonalcoholic fatty liver disease. What is the evidence?","volume":"19","author":"Memel","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib247","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol. Med."},{"key":"10.1016\/j.mam.2023.101231_bib248","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.mam.2023.101231_bib249","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12072-012-9345-8","article-title":"B cell- activating factor is associated with the histological severity of nonalcoholic fatty liver disease","volume":"7","author":"Miyake","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.mam.2023.101231_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.07.028","article-title":"Type 3 cytokines in liver fibrosis and liver cancer","volume":"124","author":"Molina","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.mam.2023.101231_bib251","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib252","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/hep.29754","article-title":"Hypoxia-inducible factor 2\u03b1 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein","volume":"67","author":"Morello","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101231_bib253","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/liv.14362","article-title":"Natural history of NASH and HCC","volume":"40","author":"Negro","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.mam.2023.101231_bib254","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib255","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib256","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3892\/ijmm_00000487","article-title":"Oxidative stress parameters in paediatric non-alcoholic fatty liver disease","volume":"26","author":"Nobili","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.mam.2023.101231_bib257","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-1536-1-5","article-title":"Redox mechanisms in hepatic chronic wound healing and fibrogenesis","volume":"1","author":"Novo","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.mam.2023.101231_bib258","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2005.069633","article-title":"Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib259","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jhep.2010.09.022","article-title":"Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells","volume":"54","author":"Novo","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib260","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/path.3005","article-title":"The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells","volume":"226","author":"Novo","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.mam.2023.101231_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108445","article-title":"Liver fibrogenesis: un update on established and emerging basic concepts","volume":"689","author":"Novo","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mam.2023.101231_bib262","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"Novobrantseva","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib263","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12915-021-01181-3","article-title":"Adipoclast: a multinucleated fat-eating macrophage","volume":"19","author":"Olona","year":"2021","journal-title":"BMC Biol."},{"key":"10.1016\/j.mam.2023.101231_bib264","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib265","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1089\/ars.2013.5619","article-title":"Role of NADPH oxidases in liver fibrosis","volume":"20","author":"Paik","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.mam.2023.101231_bib407","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","article-title":"Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release","volume":"332","author":"Pan","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib266","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2021.07.036","article-title":"Reply to: \"Baveno VI elastography criteria for ruling in cACLD works well in patients with MAFLD\" and \"Transient elastography in chronic liver disease: beware of the cut-offs!\"","volume":"75","author":"Papatheodoridi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib267","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.mam.2023.101231_bib268","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib269","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mam.2007.09.002","article-title":"Myofibroblast - like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario","volume":"29","author":"Parola","year":"2008","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.mam.2023.101231_bib270","article-title":"Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"Pastore","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.mam.2023.101231_bib271","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1172\/JCI124616","article-title":"More friend than foe: the emerging role of neutrophils in tissue repair","volume":"129","author":"Peiseler","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib272","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"issue":"6662","key":"10.1016\/j.mam.2023.101231_bib273","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq5202","article-title":"Kupffer cell-like syncytia replenish resident macrophage function in the fibrotic liver","volume":"381","author":"Peiseler","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.mam.2023.101231_bib274","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","article-title":"Thymic development of unconventional T cells: how NKT cells, MAIT cells and cd T cells emerge","volume":"20","author":"Pellicci","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib276","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1073\/pnas.0705408104","article-title":"The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome","volume":"104","author":"Petersen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2023.101231_bib277","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2015.10.016","article-title":"MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease","volume":"64","author":"Petta","year":"2016","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.mam.2023.101231_bib278","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/ijms20071629","article-title":"Human multilineage 3D spheroids as a model of liver steatosis and fibrosis","volume":"20","author":"Pingitore","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib279","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI115905","article-title":"Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients","volume":"90","author":"Pinzani","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib280","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2023.101231_bib281","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib282","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib283","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/biomedicines10010083","article-title":"Intestinal barrier and permeability in health, obesity and NAFLD","volume":"10","author":"Portincasa","year":"2021","journal-title":"Biomedicines"},{"issue":"296","key":"10.1016\/j.mam.2023.101231_bib284","doi-asserted-by":"crossref","first-page":"ra88","DOI":"10.1126\/scisignal.2004512","article-title":"Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells","volume":"6","author":"Povero","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.mam.2023.101231_bib285","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-\u03b3","volume":"1","author":"Povero","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib286","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/hep4.1556","article-title":"Characterization and proteome of circulating extracellular vesicles as potential biomarkers for NASH","volume":"4","author":"Povero","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib287","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2023.101231_bib288","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated HSCs in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib289","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13659","article-title":"Is there an 'ideal' diet for patients with NAFLD?","volume":"52","author":"Pugliese","year":"2022","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib290","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/ars.2014.6108","article-title":"Myeloperoxidase- hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis","volume":"23","author":"Pulli","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.mam.2023.101231_bib291","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2017.09.010","article-title":"Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease","volume":"81","author":"Qiao","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.mam.2023.101231_bib292","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"2","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib293","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbadis.2013.01.005","article-title":"Dendritic cells and liver fibrosis","volume":"1832","author":"Rahman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mam.2023.101231_bib294","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/liv.15157","article-title":"Integrins as a drug target in liver fibrosis","volume":"42","author":"Rahman","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.mam.2023.101231_bib295","doi-asserted-by":"crossref","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2023.101231_bib296","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib297","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41575-020-0304-x","article-title":"Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis","volume":"17","author":"Ramachandran","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib298","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhepr.2019.10.001","article-title":"Platelets in chronic liver disease, from bench to bedside","volume":"1","author":"Ramadori","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.mam.2023.101231_bib299","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.32336","article-title":"T cells: friends and foes in NASH pathogenesis and hepatocarcinogenesis","volume":"75","author":"Ramadori","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib300","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib301","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib302","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA- producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T- cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"United European Gastroenterol. J."},{"key":"10.1016\/j.mam.2023.101231_bib303","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2023.101231_bib304","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2015.08.043","article-title":"A microfluidically perfused three dimensional human liver model","volume":"71","author":"Rennert","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.mam.2023.101231_bib305","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mam.2023.101231_bib306","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","article-title":"Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction","volume":"133","author":"Richardson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib307","article-title":"NAFLD Nomenclature consensus group","author":"Rinella","year":"2023","journal-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol"},{"key":"10.1016\/j.mam.2023.101231_bib308","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis regression after eradication of hepatitis C virus: from bench to bedside","volume":"160","author":"Rockey","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance","volume":"2","author":"Roden","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib311","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2023.101231_bib312","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib313","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jcmgh.2020.06.001","article-title":"Acetyl-CoA carboxylase inhibition improves multiple dimensions of NASH pathogenesis in model systems","volume":"10","author":"Ross","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib314","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2006.01.036","article-title":"The bone marrow functionally contributes to liver fibrosis","volume":"130","author":"Russo","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib316","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and natural history of nonalcoholic fatty liver disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib317","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jhep.2020.06.004","article-title":"Single-cell genomics and spatial transcriptomics: discovery of novel cell states and cellular interactions in liver physiology and disease biology","volume":"73","author":"Saviano","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib318","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nmeth.4391","article-title":"histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data","volume":"14","author":"Schapiro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mam.2023.101231_bib319","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/hep.27982","article-title":"CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis","volume":"62","author":"Schneider","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib321","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib322","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib323","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib324","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2023.101231_bib325","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib326","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib327","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/gutjnl-2021-324339","article-title":"Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny","volume":"71","author":"Sheng","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib328","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib329","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2023.101231_bib330","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.mam.2023.101231_bib331","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib332","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib333","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib334","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mam.2023.101231_bib335","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.mam.2023.101231_bib336","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib337","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.3390\/ijms16035161","article-title":"Potential epigenetic mechanism in non-alcoholic Fatty liver disease","volume":"16","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2023.101231_bib338","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib339","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","author":"Sutti","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib340","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT- associated hedgehog and osteopontin drive fibrogenesis in non- alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.mam.2023.101231_bib341","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib342","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib343","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib344","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4049\/jimmunol.1202814","article-title":"Tim-3\/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease","volume":"190","author":"Tang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib345","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib346","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3389\/fphar.2019.01256","article-title":"Platelet-derived extracellular vesicles as target of antiplatelet agents. what is the evidence?","volume":"10","author":"Taus","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2023.101231_bib347","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib348","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.3390\/cancers13194936","article-title":"Optimization and validation of a novel three-dimensional Co-culture system in decellularized human liver scaffold for the study of liver fibrosis and cancer","volume":"13","author":"Thanapirom","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2023.101231_bib349","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/hep.27761","article-title":"Liver fibrosis occurs through dysregulation of MyD88-dependent innate B- cell activity","volume":"61","author":"Thapa","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib351","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib352","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fimmu.2017.00301","article-title":"Immunoregulatory role of NK cells in tissue inflammation and regeneration","volume":"8","author":"Tosello-Trampont","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib353","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1038\/s41467-020-17307-0","article-title":"Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity","volume":"11","author":"Toubal","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib354","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","article-title":"Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis","volume":"53","author":"Tran","year":"2020","journal-title":"Immunity"},{"issue":"1 Suppl. l","key":"10.1016\/j.mam.2023.101231_bib355","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concepts to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib356","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib357","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib358","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib359","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/ATVBAHA.114.303569","article-title":"Targeting B cells in atherosclerosis: closing the gap from bench to bedside","volume":"35","author":"Tsiantoulas","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mam.2023.101231_bib360","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2468-1253(18)30077-3","article-title":"Non-alcoholic fatty liver disease and the interface between primary and secondary care","volume":"3","author":"Tsochatzis","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol"},{"key":"10.1016\/j.mam.2023.101231_bib361","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib362","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib363","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.25617","article-title":"Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms","volume":"55","author":"Valenti","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib364","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.mam.2023.101231_bib365","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib366","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2017.07.004","article-title":"3D in vitro models of liver fibrosis","volume":"121","author":"van Grunsven","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2023.101231_bib367","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.mam.2023.101231_bib368","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3350\/cmh.2022.0205","article-title":"Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease","volume":"29","author":"Waller","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib369","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm.4290","article-title":"Targeting CASP8 and FADD- like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates","volume":"23","author":"Wang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib370","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41374-019-0342-6","article-title":"STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"100","author":"Wang","year":"2020","journal-title":"Lab. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib371","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.omtn.2021.11.008","article-title":"Dissecting the single cell transcriptome underlying chronic liver injury","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mam.2023.101231_bib372","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.21867","article-title":"Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll- like receptor 9","volume":"46","author":"Watanabe","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib373","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2023.101231_bib374","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.bbamem.2012.01.018","article-title":"The innate immune response to products of phospholipid peroxidation","volume":"1818","author":"Weismann","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mam.2023.101231_bib375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0035-1550061","article-title":"Origin and function of myofibroblasts in the liver","volume":"35","author":"Wells","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2023.101231_bib376","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI73722","article-title":"Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","author":"Weston","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mam.2023.101231_bib377","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.mam.2023.101231_bib378","article-title":"Treating inflammation to combat non-alcoholic fatty liver disease","volume":"256","author":"Wiering","year":"2022","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mam.2023.101231_bib379","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/17446651.2022.2110864","article-title":"Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis","volume":"17","author":"Wirth","year":"2022","journal-title":"Expet Rev. Endocrinol. Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib380","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross- talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2023.101231_bib381","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2008.03896.x","article-title":"Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels","volume":"29","author":"Wong","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.mam.2023.101231_bib382","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220612","article-title":"Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis","volume":"14","author":"Wong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib383","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.mam.2023.101231_bib384","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2016.02.002","article-title":"Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis","volume":"64","author":"Xiang","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186660","article-title":"Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: a systematic review and meta-analysis","volume":"12","author":"Xiao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101231_bib386","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mam.2023.101231_bib387","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","article-title":"Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice","volume":"68","author":"Xu","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib388","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib389","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mam.2023.101231_bib390","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib391","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","article-title":"Pathological features of fatty liver disease","volume":"147","author":"Yeh","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2023.101231_bib392","article-title":"Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: a post hoc analysis of a cohort study","volume":"96","author":"Yoshitaka","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.mam.2023.101231_bib398","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib393","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib394","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib395","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib396","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Global nonalcoholic steatohepatitis council. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib399","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.20783","article-title":"Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice","volume":"42","author":"Yu","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2023.101231_bib400","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0168-8278(03)00480-X","article-title":"4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells","volume":"40","author":"Zamara","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib401","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.4453","article-title":"The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib402","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nm.4334","article-title":"Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4","volume":"23","author":"Zhao","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2023.101231_bib403","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-020-2582-1","article-title":"Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mam.2023.101231_bib404","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcmgh.2018.01.003","article-title":"Neutrophil-hepatic stellate cell interactions promote fibrosis in experimental steatohepatitis","volume":"3","author":"Zhou","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2023.101231_bib405","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/cells10082072","article-title":"Feedback signaling between cholangiopathies, ductular reaction, and non-alcoholic fatty liver disease","volume":"10","author":"Zhou","year":"2021","journal-title":"Cells"},{"issue":"6382","key":"10.1016\/j.mam.2023.101231_bib406","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/358167a0","article-title":"Shigella flexneri induces apoptosis in infected macrophages","volume":"358","author":"Zychlinsky","year":"1992","journal-title":"Nature"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:57:39Z","timestamp":1777478259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299723000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":414,"alternative-id":["S0098299723000717"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2023.101231","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2023.101231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101231"}}